Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Pediatric Dermatology|May 24, 2018
Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case seriesSophie Le Sage, Michèle David, Josée Dubois, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 26, 2016
Clonidine as a First-Line Sedative Agent After Neonatal Cardiac Surgery: Retrospective Cohort StudyNiina Kleiber, Saskia N de Wildt, Gérard Cortina, et al.
Paediatrics & Child Health|May 22, 2019
Visual disorders with psychostimulants: A paediatric case reportJulie Soyer, Jennifer Jean-Louis, Luis H Ospina, et al.
Transfusion|February 2, 2018
Transfusion-associated circulatory overload in a pediatric intensive care unit: different incidences with different diagnostic criteriaLise De Cloedt, Guillaume Emeriaud, Émilie Lefebvre, et al.
Paediatric Drugs|October 31, 2014
Ethics of drug research in the pediatric intensive care unitNiina Kleiber, Krista Tromp, Miriam G Mooij, et al.
Journal of Neurosurgery. Case Lessons|August 18, 2025
Prenatal diagnosis and conservative management of a congenital cavernous sinus infantile hemangioma: illustrative caseXavier Roberge, Nalla Silva Baticam, Stéphanie Vairy, et al.
British Journal of Clinical Pharmacology|January 13, 2017
Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltrationNiina Kleiber, Ron A A Mathôt, Maurice J Ahsman, et al.
Dermatology (Basel, Switzerland)|April 6, 2021
Off-Label Use and Safety of Drug Use in Vascular AnomaliesNiina Kleiber, Laurence Gariépy-Assal, Jérôme Coulombe, et al.
Pediatric Blood & Cancer|October 1, 2021
Systemic, local, and sclerotherapy drugs: What do we know about drug prescribing in vascular anomalies?Simon Marcoux, Yves Théorêt, Josée Dubois, et al.
Pediatric Blood & Cancer|July 25, 2022
Repurposing alpelisib, an anti-cancer drug, for the treatment of severe TIE2-mutated venous malformations: Preliminary pharmacokinetics and pharmacodynamic dataAmandine Remy, Thai Hoa Tran, Josée Dubois, et al.
Pageof 4